Nectarine Health obtains the last remaining FCC clearance

Brighter's subsidiary Nectarine Health has obtained the last remaining regulatory clearance in the US linked to electronic communications (FCC). Earlier in February, Brighter announced that clearance had been obtained for two of the three units included in the system. Nectarine Health is continuing its preparations for a US commercial launch, which is planned for the second half of 2021. Nectarine Health recently also announced that the company initiated a test phase ahead of the launch. Read more about this here.

For further information, please contact:

Brighter Investor Relations
IR@brighter.se

Certified Adviser
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.